|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,297.90 INR | +0.75% |
|
-1.01% | -7.90% |
| 06-11 | AstraZeneca Pharma India Gets India Approval to Use Enhertu in Breast Cancer Treatment | MT |
| 06-04 | Indian Equities End Marginally Higher on Thursday Ahead of Central Bank's Policy Decision | MT |
| Market Cap | 194B 2.04B 1.78B 1.64B 1.53B 2.89B 2.94B 19.65B 7.64B 95.35B 7.65B 7.48B 329B | P/E 2024 |
82.4x | P/E 2025 | 186x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 1.98B 1.74B 1.59B 1.49B 2.82B 2.86B 19.14B 7.44B 92.89B 7.45B 7.29B 320B | EV / Sales 2024 |
9.88x | EV / Sales 2025 | 12.2x |
| Free-Float |
18.42% | Yield 2024 |
0.45% | Yield 2025 | 0.37% |
| 1 day | +0.75% | ||
| 1 week | -1.01% | ||
| Current month | +1.00% | ||
| 1 month | -2.93% | ||
| 3 months | +6.14% | ||
| 6 months | -3.64% | ||
| Current year | -7.90% |
| 1 week | 7,978.65 |  | 8,472.45 |
| 1 month | 7,978.65 | | 8,766.35 |
| Current year | 7,630 | | 9,219.25 |
| 1 year | 7,630 | | 9,850 |
| 3 years | 3,650.05 | | 10,653.05 |
| 5 years | 2,437.75 | | 10,653.05 |
| 10 years | 882.55 | | 10,653.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-06-30 | |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 2023-09-30 |
Sandeep Arora
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 67 | 2016-12-01 |
| Chairman | 52 | 2024-09-29 | |
Monica Widhani
BRD | Director/Board Member | 67 | 2024-09-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | -1.01% | -8.96% | +118.86% | 2.18B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 338B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 299B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 291B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.96% | +4.02% | +27.70% | +64.28% | 369.46B | |
| Weighted average by Cap. | +2.24% | +5.53% | +42.28% | +83.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.96B 136M 119M 109M 102M 193M 196M 1.31B 510M 6.37B 511M 500M 21.94B | 17.16B 180M 158M 145M 135M 256M 260M 1.74B 676M 8.44B 677M 662M 29.07B |
| Net income | 1.62B 16.96M 14.83M 13.63M 12.7M 24.09M 24.46M 164M 63.6M 794M 63.67M 62.3M 2.74B | 1.16B 12.16M 10.63M 9.77M 9.1M 17.27M 17.53M 117M 45.58M 569M 45.63M 44.65M 1.96B |
| Net Debt | -5.01B -52.62M -46M -42.27M -39.4M -74.73M -75.87M -507M -197M -2.46B -198M -193M -8.49B | -5B -52.56M -45.94M -42.22M -39.36M -74.65M -75.78M -507M -197M -2.46B -197M -193M -8.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹8,297.90 | +0.75% | 109 |
| 26-07-02 | ₹8,235.90 | +0.24% | 94 |
| 26-07-01 | ₹8,216.55 | +0.01% | 386 |
| 26-06-30 | ₹8,216.00 | +2.01% | 518 |
| 26-06-29 | ₹8,054.15 | -3.92% | 578 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ASTRAZEN Stock
Select your edition
All financial news and data tailored to specific country editions
